CN104398949A - Traditional Chinese medicine oral liquid for treating prostatitis - Google Patents
Traditional Chinese medicine oral liquid for treating prostatitis Download PDFInfo
- Publication number
- CN104398949A CN104398949A CN201410717377.9A CN201410717377A CN104398949A CN 104398949 A CN104398949 A CN 104398949A CN 201410717377 A CN201410717377 A CN 201410717377A CN 104398949 A CN104398949 A CN 104398949A
- Authority
- CN
- China
- Prior art keywords
- parts
- oral liquid
- chinese medicine
- fructus
- rhizoma dioscoreae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Abstract
The invention discloses a traditional Chinese medicine oral liquid for treating prostatitis. The traditional Chinese medicine oral liquid comprises the following effective ingredients in parts by weight: 10-20 parts of pellodendron, 10-30 parts of Chinese angelica, 6-18 parts of epimedium, 10-20 parts of Chinese yam, 6-18 parts of cortex eucommlae, 6-16 parts of rabdosia rubescens, 8-18 parts of fennel, 8-20 parts of pyrrosia lingua, 5-15 parts of earthworm, 5-15 parts of cynomorium songaricum, 8-16 parts of rhizoma dioscoreae hypoglaucae, 10-30 parts of rubus idaeus, 2-10 parts of cucurbitae semina, 4-10 parts of fructus alpiniae oxyphyllae, 6-20 parts of the fruit of Chinese wolfberry and 10-25 parts of honey. The traditional Chinese medicine oral liquid disclosed by the invention is prepared by crushing, soaking, decocting, pulping, concentrating, homogenizing, filling and sterilizing. The traditional Chinese medicine oral liquid disclosed by the invention has the advantages of abundant medicine sources in formula, low price, high convenience for taking, quick response, no toxic or side effects, high effective rate and low possibility of relapse after the disease is cured; regulation therapy is fundamentally realized; by taking the effects of clearing heat and promoting diuresis and tonifying kidney and spleen as the rule, the prostatitis is treated in a more targeted manner; the traditional Chinese medicine oral liquid is easily accepted by patients.
Description
Technical field
The invention belongs to the field of Chinese medicines, be specifically related to one and treat prostatitic Chinese medicine oral liquid.
Background technology
Prostatitis is the commonly encountered diseases of Urology Surgery, in Urology Surgery male patient the right side of fifty, account for first place.Prostatitis has following performance usually: paruria, frequent micturition is not smooth, urethra scorching hot, urine is first or urinate last pain, pain emits to Glans penis, perineal position, groin, and testis has falling inflation sense of discomfort, and urine Posterior urethral mouth adularescent secretions overflows, concurrency dysfunction once in a while, comprises hyposexuality, premature ejaculation, painful ejaculation, erection weakens and sexual impotence.Lack effective treatment means for this disease for a long time, cure rate is low always, and relapse rate is high, is one of difficult problem to be solved clinically.
Current clinical practice is main to take antibiotics anti-inflammation drugs in treatment prostatitis doctor trained in Western medicine, though can relief of symptoms, be difficult to cure, relapse rate be higher, and long-term taking antibiotic side effect is comparatively large, injures kidney.The many basic principle prescriptions by the clear sharp evil removing of real person, the righting of nourishing for deficiency kidney of Chinese traditional treatment, Chinese prescription contains a lot of composition, not only has eliminating effect to inflammation, and can alleviate the status of drug resistance of western medical treatment to a certain extent, alleviate the side effect of western medical treatment, not easily recur after healing.
Summary of the invention
The object of the present invention is to provide one to treat prostatitic Chinese medicine oral liquid, this medicine can rapid delivery lesions position, effectively treats prostatitis, and not easily recurs after curing.
The present invention's adopted technical scheme that solves the problem is:
One treats prostatitic Chinese medicine oral liquid, and the parts by weight of raw materials making oral liquid effective ingredient is: Cortex Phellodendri 10-20 part, Radix Angelicae Sinensis 10-30 part, Herba Epimedii 6-18 part, Rhizoma Dioscoreae 10-20 part, Cortex Eucommiae 6-18 part, Rabdosia rubescens 6-16 part, Fructus Foeniculi 8-18 part, Folium Pyrrosiae 8-20 part, Pheretima 5-15 part, Herba Cynomorii 5-15 part, Rhizoma Dioscoreae Septemlobae 8-16 part, Fructus Rubi 10-30 part, Semen Cucurbitae 2-10 part, Fructus Alpiniae Oxyphyllae 4-10 part, Fructus Lycii 6-20 part, Mel 10-25 part.
Further, the parts by weight of raw materials making oral liquid effective ingredient is: Cortex Phellodendri 13-17 part, Radix Angelicae Sinensis 15-25 part, Herba Epimedii 10-14 part, Rhizoma Dioscoreae 13-17 part, Cortex Eucommiae 9-15 part, Rabdosia rubescens 9-13 part, Fructus Foeniculi 11-15 part, Folium Pyrrosiae 11-17 part, Pheretima 8-13 part, Herba Cynomorii 7-12 part, Rhizoma Dioscoreae Septemlobae 10-14 part, Fructus Rubi 15-25 part, Semen Cucurbitae 4-8 part, Fructus Alpiniae Oxyphyllae 6-8 part, Fructus Lycii 10-16 part, Mel 15-20 part.
Further, the parts by weight of raw materials making oral liquid effective ingredient is: Cortex Phellodendri 15 parts, Radix Angelicae Sinensis 20 parts, Herba Epimedii 12 parts, Rhizoma Dioscoreae 15 parts, the Cortex Eucommiae 12 parts, Rabdosia rubescens 11 parts, Fructus Foeniculi 13 parts, Folium Pyrrosiae 14 parts, Pheretima 10 parts, Herba Cynomorii 10 parts of, Rhizoma Dioscoreae Septemlobae 12 parts, Fructus Rubi 20 parts, Semen Cucurbitae 6 parts, Fructus Alpiniae Oxyphyllae 7 parts, Fructus Lycii 13 parts, Mel 20 parts.
The present invention also provides a kind of preparation method for the treatment of prostatitic Chinese medicine oral liquid, and described preparation method comprises the following steps:
(1) pulverize: take Cortex Phellodendri, Radix Angelicae Sinensis, Herba Epimedii, the Cortex Eucommiae, Rabdosia rubescens, Fructus Foeniculi, Folium Pyrrosiae, Pheretima, Herba Cynomorii, Rhizoma Dioscoreae Septemlobae, Fructus Alpiniae Oxyphyllae by formula, then mix homogeneously pulverizing, obtain Chinese medicine mixed-powder;
(2) soak: the water Chinese medicine mixed-powder of step (1) gained being added 5-7 times amount, soak 30-60min;
(3) decoct: the Chinese medicine mixed-powder after step (2) being soaked decocts, and decocts 1h, decoction liquor sucking filtration, in concentration tank, repeats to decoct once, merges twice decoction liquor;
(4) defibrination: cutting is cleaned in Rhizoma Dioscoreae peeling, chooses fresh Fructus Rubi and cleans, then Rhizoma Dioscoreae, Fructus Rubi, Semen Cucurbitae, Fructus Lycii and suitable quantity of water are sent into fiberizer and carry out defibrination, filter, obtain mixed liquor;
(5) concentrated: step (3) gained decoction liquor mixed homogeneously with step (4) gained mixed liquor, being evaporated to relative density is 1.15-1.20, collect concentrated solution, leave standstill 12h, for subsequent use;
(6) homogenizing: add Mel, mix homogeneously by after the concentrated solution heated and boiled of step (5) gained, and carry out homogenizing;
(7) fill: filtered by the concentrated solution after step (6) homogenizing, fill, is distributed into 10mL/ bottle, gland seal;
(8) sterilizing: loaded in sterilizing cabinet by the medicine bottle of step (7) gained filling and sealing, 115 DEG C of saturated vapors carry out sterilizing, cooling, obtains the prostatitic Chinese medicine oral liquid of described treatment.
The traditional Chinese medical science thinks that prostatitis is the damp-heat accumulation part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, the turbid retardance of the stasis of blood, consumption be impairment of the kidney essence etc. caused by, damp and hot is the mark of primary disease, kidney asthenia as the principal aspect sick this, qi depression to blood stasis is the pathomechanism that primary disease further develops, treatment should be general provisions with " giving consideration to both the incidental and fundamental; dampness removing leads to stasis of blood tonify deficiency ", eliminating damp-heat, disperse blood stasis and dredge collateral should take stopgap measures, also wants tonify deficiency strengthening the body resistance.The Cortex Eucommiae, Herba Cynomorii the kidney invigorating in side, Pheretima can control weakness of the spleen and kidney, Fructus Alpiniae Oxyphyllae energy warming the kidney solid and gas, and four share the effect reaching strengthening spleen, tonifying kidney, is be monarch drug; Herba Epimedii energy tonify deficiency is supporing yang, Cortex Phellodendri, Rabdosia rubescens heat clearing and damp drying ， Rhizoma Dioscoreae Septemlobae expelling wind and removing dampness, Folium Pyrrosiae inducing diuresis for treating stranguria syndrome, and above all medicine energy clearing away heat-damp and promoting diuresis, are ministerial drug; Radix Angelicae Sinensis blood circulation promoting and enriching, Fructus Rubi, Semen Cucurbitae, Fructus Lycii nourishing the liver and kidney, replenishing vital essence to improve eyesight are adjuvant drug altogether; Rhizoma Dioscoreae spleen reinforcing nourishing the stomach, the kidney invigorating arresting seminal emission, Fructus Foeniculi dispersing cold for relieving pain, regulating qi-flowing for harmonizing stomach is for making medicine; More there is the invigorating middle warmer of Mel QI invigorating, analgesic antidotal, and hundred medicines, become the medicine of strengthening vital QI to eliminate pathogenic factors altogether, on the basis of vital energy benefiting and the kidney invigorating, add the medicine of clearing away heat-damp and promoting diuresis to reach the object for the treatment of both the principal and secondary aspects of a disease.
The invention has the beneficial effects as follows:
(1) magistral medicines source of the present invention is enriched, cheap, taking convenience, and patient takes like a shot;
(2) fundamentally overall conditioning and treating, with clearing away heat-damp and promoting diuresis, kidney and spleen invigorating for the rule for the treatment of, treats prostatitis more targetedly;
(3) instant effect, has no side effect, and effective percentage is high, not easily recurs after healing.
Beneficial effect of the present invention is further illustrated below in conjunction with clinical laboratory data.
(1) clinical data
Recruit 178 routine patients in certain hospital, all meet the diagnostic criteria in " guideline of clinical investigations of new Chinese medicine treatment chronic prostatitis (non-specific) ".Patient age is between 20-50 year, and the course of disease is more than half a year.
(2) diagnostic criteria
According to People's Republic of China's Chinese medicine professional standard " surgery of Chinese medicine disease Standardization of diagnosis and curative effect ": paruria, frequent micturition is not smooth, urethra scorching hot, urine is first or urinate last pain, pain emits to Glans penis, perineal position, groin, and testis has falling inflation sense of discomfort, and urine Posterior urethral mouth adularescent secretions overflows, concurrency dysfunction once in a while, comprises hyposexuality, premature ejaculation, painful ejaculation, erection weakens and sexual impotence.
(3) Therapeutic Method
Oral, every day twice, sooner or later respectively once, and each one bottle, 15 days 1 courses for the treatment of.
(4) efficacy assessment standard
Cure: clinical symptoms all disappears, and test chamber inspection is normal;
Effective: clinical symptom relief, the state of an illness is controlled, lab testing improvement or normal;
Invalid: clinical symptoms is without being clearly better or increasing the weight of.
(5) therapeutic outcome
In 178 routine patients, after taking Chinese medicine oral liquid of the present invention, cure 165 examples, effective 10 examples, invalid 3 examples, total cure rate is 92.7%, and total effective rate is 98.3%.
(6) model case
Case 1: what certain, man, 37 years old, frequent micturition is not smooth, dysuria, perineum and scrotum, urethralgia, bitter taste, red tongue, yellow and greasy fur, stringy and rolling pulse, is diagnosed as prostatitis on inspection, after taking 2 courses for the treatment of of this Chinese medicine oral liquid, symptom is clearly better, and after continuing to take 2 courses for the treatment of, patients symptomatic disappears, prostatitis is cured, and follows up a case by regular visits to without recurrence after half a year.
Case 2: grandson, man, 42 years old, frequent micturition, burning on urination, urine retention, testis has falling inflation sense of discomfort, and urine Posterior urethral mouth adularescent secretions overflows, soreness of the waist and knees, spiritlessness and weakness, be diagnosed as prostatitis on inspection, after taking 2 courses for the treatment of of this Chinese medicine oral liquid, symptom is clearly better, after continuing to take 3 courses for the treatment of, patients symptomatic disappears, and prostatitis is cured, and follows up a case by regular visits to without recurrence after 1 year.
Detailed description of the invention
Below in conjunction with embodiments of the invention, technical scheme of the present invention is clearly and completely described.
Embodiment 1
One treats prostatitic Chinese medicine oral liquid, and the parts by weight of raw materials making oral liquid effective ingredient is: Cortex Phellodendri 10 parts, Radix Angelicae Sinensis 10 parts, Herba Epimedii 6 parts, Rhizoma Dioscoreae 10 parts, the Cortex Eucommiae 6 parts, Rabdosia rubescens 6 parts, Fructus Foeniculi 8 parts, Folium Pyrrosiae 8 parts, Pheretima 5 parts, Herba Cynomorii 5 parts of, Rhizoma Dioscoreae Septemlobae 8 parts, Fructus Rubi 10 parts, Semen Cucurbitae 2 parts, Fructus Alpiniae Oxyphyllae 4 parts, Fructus Lycii 6 parts, Mel 10 parts.
The preparation method of the prostatitic Chinese medicine oral liquid of described treatment comprises the following steps:
(1) pulverize: take Cortex Phellodendri, Radix Angelicae Sinensis, Herba Epimedii, the Cortex Eucommiae, Rabdosia rubescens, Fructus Foeniculi, Folium Pyrrosiae, Pheretima, Herba Cynomorii, Rhizoma Dioscoreae Septemlobae, Fructus Alpiniae Oxyphyllae by formula, then mix homogeneously pulverizing, obtain Chinese medicine mixed-powder;
(2) soak: the water Chinese medicine mixed-powder of step (1) gained being added 5-7 times amount, soak 30-60min;
(3) decoct: the Chinese medicine mixed-powder after step (2) being soaked decocts, and decocts 1h, decoction liquor sucking filtration, in concentration tank, repeats to decoct once, merges twice decoction liquor;
(4) defibrination: cutting is cleaned in Rhizoma Dioscoreae peeling, chooses fresh Fructus Rubi and cleans, then Rhizoma Dioscoreae, Fructus Rubi, Semen Cucurbitae, Fructus Lycii and suitable quantity of water are sent into fiberizer and carry out defibrination, filter, obtain mixed liquor;
(5) concentrated: step (3) gained decoction liquor mixed homogeneously with step (4) gained mixed liquor, being evaporated to relative density is 1.15-1.20, collect concentrated solution, leave standstill 12h, for subsequent use;
(6) homogenizing: add Mel, mix homogeneously by after the concentrated solution heated and boiled of step (5) gained, and carry out homogenizing;
(7) fill: filtered by the concentrated solution after step (6) homogenizing, fill, is distributed into 10mL/ bottle, gland seal;
(8) sterilizing: loaded in sterilizing cabinet by the medicine bottle of step (7) gained filling and sealing, 115 DEG C of saturated vapors carry out sterilizing, cooling, obtains the prostatitic Chinese medicine oral liquid of described treatment.
Embodiment 2
One treats prostatitic Chinese medicine oral liquid, and the parts by weight of raw materials making oral liquid effective ingredient is: Cortex Phellodendri 20 parts, Radix Angelicae Sinensis 30 parts, Herba Epimedii 18 parts, Rhizoma Dioscoreae 20 parts, the Cortex Eucommiae 18 parts, Rabdosia rubescens 16 parts, Fructus Foeniculi 18 parts, Folium Pyrrosiae 20 parts, Pheretima 15 parts, Herba Cynomorii 15 parts of, Rhizoma Dioscoreae Septemlobae 16 parts, Fructus Rubi 30 parts, Semen Cucurbitae 10 parts, Fructus Alpiniae Oxyphyllae 10 parts, Fructus Lycii 20 parts, Mel 25 parts.
The preparation method of the prostatitic Chinese medicine oral liquid for the treatment of of the present embodiment is identical with embodiment 1.
Embodiment 3
One treats prostatitic Chinese medicine oral liquid, and the parts by weight of raw materials making oral liquid effective ingredient is: Cortex Phellodendri 13 parts, Radix Angelicae Sinensis 15 parts, Herba Epimedii 10 parts, Rhizoma Dioscoreae 13 parts, the Cortex Eucommiae 9 parts, Rabdosia rubescens 9 parts, Fructus Foeniculi 11 parts, Folium Pyrrosiae 11 parts, Pheretima 8 parts, Herba Cynomorii 7 parts of, Rhizoma Dioscoreae Septemlobae 10 parts, Fructus Rubi 15 parts, Semen Cucurbitae 4 parts, Fructus Alpiniae Oxyphyllae 6 parts, Fructus Lycii 10 parts, Mel 15 parts.
The preparation method of the prostatitic Chinese medicine oral liquid for the treatment of of the present embodiment is identical with embodiment 1.
Embodiment 4
One treats prostatitic Chinese medicine oral liquid, and the parts by weight of raw materials making oral liquid effective ingredient is: Cortex Phellodendri 17 parts, Radix Angelicae Sinensis 25 parts, Herba Epimedii 14 parts, Rhizoma Dioscoreae 17 parts, the Cortex Eucommiae 15 parts, Rabdosia rubescens 13 parts, Fructus Foeniculi 15 parts, Folium Pyrrosiae 17 parts, Pheretima 13 parts, Herba Cynomorii 12 parts of, Rhizoma Dioscoreae Septemlobae 14 parts, Fructus Rubi 25 parts, Semen Cucurbitae 8 parts, Fructus Alpiniae Oxyphyllae 8 parts, Fructus Lycii 16 parts, Mel 20 parts.
The preparation method of the prostatitic Chinese medicine oral liquid for the treatment of of the present embodiment is identical with embodiment 1.
Embodiment 5
One treats prostatitic Chinese medicine oral liquid, and the parts by weight of raw materials making oral liquid effective ingredient is: Cortex Phellodendri 15 parts, Radix Angelicae Sinensis 20 parts, Herba Epimedii 12 parts, Rhizoma Dioscoreae 15 parts, the Cortex Eucommiae 12 parts, Rabdosia rubescens 11 parts, Fructus Foeniculi 13 parts, Folium Pyrrosiae 14 parts, Pheretima 10 parts, Herba Cynomorii 10 parts of, Rhizoma Dioscoreae Septemlobae 12 parts, Fructus Rubi 20 parts, Semen Cucurbitae 6 parts, Fructus Alpiniae Oxyphyllae 7 parts, Fructus Lycii 13 parts, Mel 20 parts.
The preparation method of the prostatitic Chinese medicine oral liquid for the treatment of of the present embodiment is identical with embodiment 1.
Embodiment 6
One treats prostatitic Chinese medicine oral liquid, and the parts by weight of raw materials making oral liquid effective ingredient is: Cortex Phellodendri 13 parts, Radix Angelicae Sinensis 19 parts, Herba Epimedii 18 parts, Rhizoma Dioscoreae 16 parts, the Cortex Eucommiae 15 parts, Rabdosia rubescens 8 parts, Fructus Foeniculi 11 parts, Folium Pyrrosiae 13 parts, Pheretima 7 parts, Herba Cynomorii 13 parts of, Rhizoma Dioscoreae Septemlobae 13 parts, Fructus Rubi 25 parts, Semen Cucurbitae 10 parts, Fructus Alpiniae Oxyphyllae 8 parts, Fructus Lycii 16 parts, Mel 25 parts.
The preparation method of the prostatitic Chinese medicine oral liquid for the treatment of of the present embodiment is identical with embodiment 1.
The above is the preferred embodiment of the present invention; its object is to allow person skilled in the art understand content of the present invention and to be implemented; should be understood that; for those skilled in the art; under the premise without departing from the principles of the invention; can also make some improvements and modifications, these improvements and modifications are also considered as protection scope of the present invention.
Claims (4)
1. the prostatitic Chinese medicine oral liquid for the treatment of, it is characterized in that, the parts by weight of raw materials making oral liquid effective ingredient is: Cortex Phellodendri 10-20 part, Radix Angelicae Sinensis 10-30 part, Herba Epimedii 6-18 part, Rhizoma Dioscoreae 10-20 part, Cortex Eucommiae 6-18 part, Rabdosia rubescens 6-16 part, Fructus Foeniculi 8-18 part, Folium Pyrrosiae 8-20 part, Pheretima 5-15 part, Herba Cynomorii 5-15 part, Rhizoma Dioscoreae Septemlobae 8-16 part, Fructus Rubi 10-30 part, Semen Cucurbitae 2-10 part, Fructus Alpiniae Oxyphyllae 4-10 part, Fructus Lycii 6-20 part, Mel 10-25 part.
2. one as claimed in claim 1 treats prostatitic Chinese medicine oral liquid, it is characterized in that, the parts by weight of raw materials making oral liquid effective ingredient is: Cortex Phellodendri 13-17 part, Radix Angelicae Sinensis 15-25 part, Herba Epimedii 10-14 part, Rhizoma Dioscoreae 13-17 part, Cortex Eucommiae 9-15 part, Rabdosia rubescens 9-13 part, Fructus Foeniculi 11-15 part, Folium Pyrrosiae 11-17 part, Pheretima 8-13 part, Herba Cynomorii 7-12 part, Rhizoma Dioscoreae Septemlobae 10-14 part, Fructus Rubi 15-25 part, Semen Cucurbitae 4-8 part, Fructus Alpiniae Oxyphyllae 6-8 part, Fructus Lycii 10-16 part, Mel 15-20 part.
3. one as claimed in claim 1 treats prostatitic Chinese medicine oral liquid, it is characterized in that, the parts by weight of raw materials making oral liquid effective ingredient is: Cortex Phellodendri 15 parts, Radix Angelicae Sinensis 20 parts, Herba Epimedii 12 parts, Rhizoma Dioscoreae 15 parts, the Cortex Eucommiae 12 parts, Rabdosia rubescens 11 parts, Fructus Foeniculi 13 parts, Folium Pyrrosiae 14 parts, Pheretima 10 parts, Herba Cynomorii 10 parts of, Rhizoma Dioscoreae Septemlobae 12 parts, Fructus Rubi 20 parts, Semen Cucurbitae 6 parts, Fructus Alpiniae Oxyphyllae 7 parts, Fructus Lycii 13 parts, Mel 20 parts.
4. prepare a preparation method for the prostatitic Chinese medicine oral liquid for the treatment of as described in claim 1-3 any one, it is characterized in that, comprise the following steps:
(1) pulverize: take Cortex Phellodendri, Radix Angelicae Sinensis, Herba Epimedii, the Cortex Eucommiae, Rabdosia rubescens, Fructus Foeniculi, Folium Pyrrosiae, Pheretima, Herba Cynomorii, Rhizoma Dioscoreae Septemlobae, Fructus Alpiniae Oxyphyllae by formula, then mix homogeneously pulverizing, obtain Chinese medicine mixed-powder;
(2) soak: the water Chinese medicine mixed-powder of step (1) gained being added 5-7 times amount, soak 30-60min;
(3) decoct: the Chinese medicine mixed-powder after step (2) being soaked decocts, and decocts 1h, decoction liquor sucking filtration, in concentration tank, repeats to decoct once, merges twice decoction liquor;
(4) defibrination: cutting is cleaned in Rhizoma Dioscoreae peeling, chooses fresh Fructus Rubi and cleans, then Rhizoma Dioscoreae, Fructus Rubi, Semen Cucurbitae, Fructus Lycii and suitable quantity of water are sent into fiberizer and carry out defibrination, filter, obtain mixed liquor;
(5) concentrated: step (3) gained decoction liquor mixed homogeneously with step (4) gained mixed liquor, being evaporated to relative density is 1.15-1.20, collect concentrated solution, leave standstill 12h, for subsequent use;
(6) homogenizing: add Mel, mix homogeneously by after the concentrated solution heated and boiled of step (5) gained, and carry out homogenizing;
(7) fill: filtered by the concentrated solution after step (6) homogenizing, fill, is distributed into 10mL/ bottle, gland seal;
(8) sterilizing: loaded in sterilizing cabinet by the medicine bottle of step (7) gained filling and sealing, 115 DEG C of saturated vapors carry out sterilizing, cooling, obtains the prostatitic Chinese medicine oral liquid of described treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410717377.9A CN104398949B (en) | 2014-11-29 | 2014-11-29 | One kind treats prostatitic traditional Chinese medicine oral liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410717377.9A CN104398949B (en) | 2014-11-29 | 2014-11-29 | One kind treats prostatitic traditional Chinese medicine oral liquid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104398949A true CN104398949A (en) | 2015-03-11 |
| CN104398949B CN104398949B (en) | 2018-02-23 |
Family
ID=52636658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410717377.9A Expired - Fee Related CN104398949B (en) | 2014-11-29 | 2014-11-29 | One kind treats prostatitic traditional Chinese medicine oral liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104398949B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106310085A (en) * | 2016-11-11 | 2017-01-11 | 东莞市百替生物科技有限公司 | Traditional Chinese medicine composition for treating chronic prostatitis and preparation method |
| CN112546126A (en) * | 2019-09-25 | 2021-03-26 | 姚江荣 | Medicine for treating prostatitis and/or prostatic hyperplasia, preparation method thereof and medicine box containing medicine |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102100845A (en) * | 2011-01-25 | 2011-06-22 | 李文杰 | Medicament for treating deficiency of kidney, frequent micturition, urgent urination and prostatitis |
| CN102973865A (en) * | 2012-11-07 | 2013-03-20 | 溧阳市天目湖保健品有限公司 | Formula of traditional Chinese medicine used for treating prostatitis |
-
2014
- 2014-11-29 CN CN201410717377.9A patent/CN104398949B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102100845A (en) * | 2011-01-25 | 2011-06-22 | 李文杰 | Medicament for treating deficiency of kidney, frequent micturition, urgent urination and prostatitis |
| CN102973865A (en) * | 2012-11-07 | 2013-03-20 | 溧阳市天目湖保健品有限公司 | Formula of traditional Chinese medicine used for treating prostatitis |
Non-Patent Citations (2)
| Title |
|---|
| 崔晓丽: "《粥膳汤饮养疗全书》", 31 January 2014, 中国人口出版社 * |
| 贺菊乔，等: "《外科疾病药疗食疗全书》", 30 September 2009, 湖南科学技术出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106310085A (en) * | 2016-11-11 | 2017-01-11 | 东莞市百替生物科技有限公司 | Traditional Chinese medicine composition for treating chronic prostatitis and preparation method |
| CN112546126A (en) * | 2019-09-25 | 2021-03-26 | 姚江荣 | Medicine for treating prostatitis and/or prostatic hyperplasia, preparation method thereof and medicine box containing medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104398949B (en) | 2018-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106110110A (en) | Treatment hyperosteogeny, cervical spondylosis, lumbar spondylosis, arthritic plaster | |
| CN105816832A (en) | Traditional Chinese medicine gel plaster for treating wind-cold lumbago and preparation method thereof | |
| CN103432501B (en) | A kind of preparation method of the Chinese medicine composition and preparation thereof for treating chronic colitis | |
| CN104398949B (en) | One kind treats prostatitic traditional Chinese medicine oral liquid | |
| CN103585585B (en) | A kind of Chinese medicine composition for the treatment of choledocholithiasis and preparation method thereof | |
| CN103083616B (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN103083617B (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
| CN102370853A (en) | Traditional Chinese medicine for treating chronic pyelonephritis | |
| CN106309716A (en) | External use traditional Chinese medicine moxa-preparation for treating damp-heat and blood-stasis obstruction type prostatitis | |
| CN102973866B (en) | Traditional Chinese medicine compound navel patch for treating prostate disease | |
| CN103536671A (en) | Drug for treating ischialgia | |
| CN103656531B (en) | A kind of Chinese medicine for the treatment of urticaria | |
| CN106421172A (en) | Combinational traditional Chinese medicine for curing male infertility | |
| CN101658648B (en) | Medicament for treating cervical erosion | |
| CN106256372A (en) | A kind of endo-medicine treating chronic prostatitis and preparation method thereof | |
| CN106038886A (en) | Medicinal liquid for acupuncture for treating cervical spondylosis with symptom of hyperosteogeny and preparation method of medicinal liquid for acupuncture for treating cervical spondylosis with symptom of hyperosteogeny | |
| CN105687909A (en) | Traditional Chinese medicine composition for treating dysuria | |
| CN105148051A (en) | Traditional Chinese medicinal composition for treating chronic prostatitis | |
| CN105797037A (en) | Traditional Chinese medicine composition for treating chronic urinary system infection | |
| CN104524133A (en) | Traditional Chinese medicinal composition for kidney tonifying, exterior strengthening and beauty treating | |
| CN105362786A (en) | Traditional Chinese medicine capsules for treating gall-stone and preparation method thereof | |
| CN104922590A (en) | Traditional Chinese medicine composition for treating chronic prostatitis | |
| CN104352846A (en) | Traditional Chinese medicinal composition for treating senile constipation | |
| CN104740035A (en) | Traditional Chinese medicine for treating icteritious hepatitis | |
| CN101439110B (en) | Chinese medicine for curing rheumatism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180223 Termination date: 20181129 |